Skip NavigationSkip to Content

The Rho/Rac Guanine Nucleotide Exchange Factor Vav1 Regulates Hif-1 alpha and Glut-1 Expression and Glucose Uptake in the Brain

  1. Author:
    Hong,Jaewoo
    Kim, Yurim
    Yanpallewar,Sudhirkumar
    Lin,Charles
  2. Author Address

    NCI, Canc & Inflammat Program, Ctr Canc Res, Frederick, MD 21702 USA.Univ Maryland, Dept Biol, College Pk, MD 20742 USA.NCI, Mouse Canc Genet Program, Ctr Canc Res, Frederick, MD 21702 USA.
    1. Year: 2020
    2. Date: FEB
    3. Epub Date: 2020 02 17
  1. Journal: International journal of molecular sciences
  2. MDPI,
    1. 21
    2. 4
  3. Type of Article: Article
  4. Article Number: 1341
  5. ISSN: 1422-0067
  1. Abstract:

    Vav1 is a Rho/Rac (Ras-related C3 botulinum toxin substrate) guanine nucleotide exchange factor expressed in hematopoietic and endothelial cells that are involved in a wide range of cellular functions. It is also stabilized under hypoxic conditions when it regulates the accumulation of the transcription factor HIF (Hypoxia Inducible Factor)-1 alpha, which activates the transcription of target genes to orchestrate a cellular response to low oxygen. One of the genes induced by HIF-1 alpha is GLUT (Glucose Transporter)-1, which is the major glucose transporter expressed in vessels that supply energy to the brain. Here, we identify a role for Vav1 in providing glucose to the brain. We found that Vav1 deficiency downregulates HIF-1 alpha and GLUT-1 levels in endothelial cells, including blood-brain barrier cells. This downregulation of GLUT-1, in turn, reduced glucose uptake to endothelial cells both in vitro and in vivo, and reduced glucose levels in the brain. Furthermore, endothelial cell-specific Vav1 knock-out in mice, which caused glucose uptake deficiency, also led to a learning delay in fear conditioning experiments. Our results suggest that Vav1 promotes learning by activating HIF-1 alpha and GLUT-1 and thereby distributing glucose to the brain. We further demonstrate the importance of glucose transport by endothelial cells in brain functioning and reveal a potential new axis for targeting GLUT-1 deficiency syndromes and other related brain diseases.

    See More

External Sources

  1. DOI: 10.3390/ijms21041341
  2. PMID: 32079227
  3. WOS: 000522524400168

Library Notes

  1. Fiscal Year: FY2019-2020
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel